Sign In
Buy IRWD
$3.24
-0.0400 (-1.22%)
At Close: Jun 03, 2026
Google launches new Ironwood chip to speed AI applications
08:12am, Wednesday, 09'th Apr 2025
Alphabet's on Wednesday unveiled its seventh-generation artificial intelligence chip named Ironwood, which the company said is designed to speed the performance of AI applications.
Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing
04:05pm, Thursday, 27'th Mar 2025
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (the “Company”) (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastro
Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund
08:30am, Tuesday, 25'th Mar 2025
SAN ANTONIO--(BUSINESS WIRE)--Ironwood Midstream Energy Partners III, LLC (Ironwood III) today announced it has secured a substantial equity commitment from Kayne Anderson Energy Infrastructure Fund,
Billionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 Stocks
03:01pm, Monday, 17'th Mar 2025
If you work in the biotech industry, you might know the name Alex Denner.
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
12:46pm, Friday, 28'th Feb 2025
Ironwood reports weaker-than-expected results for the fourth quarter of 2024. The company maintains total revenue guidance for 2025.
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript
11:21am, Thursday, 27'th Feb 2025
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Greg Martini - Chief Financial Officer Tom McCourt - Chief Executive Of
Ironwood Pharmaceuticals (IRWD) Q4 Earnings and Revenues Miss Estimates
09:20am, Thursday, 27'th Feb 2025
Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to break-even earnings per share a year ago.
Millrose Properties Set to Join S&P SmallCap 600
06:28pm, Wednesday, 05'th Feb 2025
NEW YORK , Feb. 5, 2025 /PRNewswire/ -- Millrose Properties Inc. (NYSE: MRP) will replace Ironwood Pharmaceuticals Inc. (NASD: IRWD) in the S&P SmallCap 600 effective prior to the opening of trading o
IRWD Begins Apraglutide NDA Submission, Announces Job Cuts, Stock Falls
12:51pm, Thursday, 30'th Jan 2025
Ironwood begins the rolling NDA filing for apraglutide to treat short bowel syndrome patients dependent on parenteral support.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
08:07am, Friday, 17'th Jan 2025
The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. It kicks off the second phase of a landmark provision in
Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
04:01pm, Tuesday, 26'th Nov 2024
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wed
Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
04:01pm, Wednesday, 13'th Nov 2024
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at th
Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
12:06pm, Friday, 08'th Nov 2024
IRWD's third-quarter earnings miss estimates while revenues beat the same. The company maintains revenue guidance for 2024.
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript
10:34pm, Thursday, 07'th Nov 2024
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q3 2024 Earnings Call Transcript November 7, 2024 8:30 AM ET Company Participants Matt Roache - Director of Investor Relations Tom McCourt - Chief Executi
Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates
09:21am, Thursday, 07'th Nov 2024
Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.12 per share a year ago.
